http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2298757-T3
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_05a203d85ee01909eaf728dc16f0f6cb |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-73 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-73 |
| filingDate | 2004-05-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2008-05-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1e991dd827c2a6887aee0d6188377dfe http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_18a85dd5749d2a7c706564ebac07555a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b872cadbec9f5cb3afc8cd23aef15f0c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e18699e39c862ee16586da52f769575d |
| publicationDate | 2008-05-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | ES-2298757-T3 |
| titleOfInvention | DERIVATIVES OF Z-AMINO-PIRIDINA AS BETA-2 ADRECORRECEPTORS AGONISTS. |
| abstract | A compound of formula (1): (See formula) in which the group CH2-C (= O) NH-benzyl-Q 1 -Q 2 -Q 3 -Q 4 is in the meta or para position, and R 1 and R2 are independently selected from H and C1-C4 alkyl; Q 1 is (CH2) n in which n is an integer selected from 0 and 1; Q 2 is a group selected from NH, -C (= O) NH-, -NHC (= O) -, -NH-C (O) -NH and -SO2NH-; Q 3 is a single bond, a C1-C4 alkylene optionally substituted with OH or a group (CH2) m-O- (CH2) p in which m and p are whole numbers independently selected from 1, 2 or 3; Q 4 is selected from: (See formula) where * represents the point of attachment to Q 3 and R 3, R 4, R 5, R 6 and R 7 are independently selected from H, phenoxy, C1-C4 alkyl, OR 9, SR 9, halo, CF3, OCF3, COOR 9, SO2NR 8 R 9, CONR 8 R 9, NHR 8 R 9, NHCOR 9, CH2-NHC (= O) NH-R 9 with the condition that at minus 2 of R 3 to R 7 are equal to H; wherein R 8 is selected from H or C1-C4 alkyl and R 9 is selected from H, C1-C4 alkyl, benzyl optionally substituted with 1, 2, 3 or 4 C1-C4 alkoxy and a group (See formula) in which q is an integer selected from 0, 1, 2 and 3; or, if appropriate, its pharmaceutically acceptable salts and / or isomers, tautomers, solvates or isotopic variations thereof. |
| priorityDate | 2003-06-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 417.